Key facts
- This page summarizes Jay R. Venkatesan's Form 4 filing for Elicio Therapeutics, Inc. (ELTX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Nov 2024, 07:39.
Jay R. Venkatesan - 26 Nov 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)
- Reporting relationship
- Director
- Issuer ticker
- ELTX
- Reported as of
- 26 Nov 2024
- Net transaction value
- +$500
- SEC form
- 4
- Accepted by SEC
- 29 Nov 2024, 07:39:46 UTC
- Prior SEC filing
- 25 Nov 2024
- Next SEC filing
- 13 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jay Venkatesan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jay R. Venkatesan filed Form 4 for Elicio Therapeutics, Inc. (ELTX) on 29 Nov 2024.
Change
- Previous filing in this sequence was filed on 25 Nov 2024.
- Current net transaction value: +$500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELTX
transaction
Common Stock
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $500
- Shares
- +50,000
- Change %
- +39%
- Price
- $0.0100
- Shares after
- 179,581
- Date
- 26 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
ELTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 953
- Date
- 26 Nov 2024
- Ownership
- By Trust
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELTX
transaction
Derivative
Warrant to Purchase Common Stock
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $0
- Shares
- -50,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 26 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $0.0100
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On November 26, 2024, the Reporting Person exercised a pre-funded warrant to purchase an aggregate of 50,000 shares of the Issuer's common stock.
Footnote F2
The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any.
Footnote F3
N/A